Dermapharm Holding SE
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DMPHF research report →
Price Chart
About the company
Dermapharm Holding SE is an international pharmaceutical company specializing in off-patent branded medications, serving both domestic and global markets. Its business is structured across three distinct segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Imports, and Herbal Extracts. The company's comprehensive activities encompass the development, production, licensing, marketing, and distribution of its offerings.
- CEO
- Hans-Georg Feldmeier
- IPO
- 2022
- Employees
- 3,500
- HQ
- Grünwald, BV, DE
Get TickerSpark's AI analysis on DMPHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.36B
- P/E
- 13.75
- Fwd P/E
- 18.53
- PEG
- 0.35
- P/S
- 1.60
- P/B
- 3.52
- EV/EBITDA
- 8.47
- Div Yield
- 2.31%
- Gross Margin
- 34.73%
- Op Margin
- 22.03%
- Net Margin
- 12.40%
- ROE
- 22.38%
- ROIC
- 10.15%
Latest fiscal year · YoY change
- Revenue
- $1.16B-1.4%
- Gross Profit
- $391.56M-49.0%
- Op Income
- $221.66M
- Net Income
- $132.36M+16.3%
- EPS
- $2.46+16.6%
- OCF Growth
- -9.9%
- FCF Growth
- -14.6%
- 52W High
- $59.00
- 52W Low
- $39.56
- 50D MA
- $47.69
- 200D MA
- $43.21
- Beta
- 0.85
- RSI (14)
- 38
- Avg Volume
- 1
No earnings-call transcripts are available for DMPHF yet.
- Free Float
- 22.5%
- Shares Outstanding
- 49.54M
- Float Shares
- 11.14M
Our DMPHF coverage
Recent articles, reports, and earnings notes.
No research on DMPHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DMPHF report →